netFormulary

North East and North Cumbria
ICS Formulary

6 Endocrine system

06-04-01-01 Oestrogens and Hormone Replacement Therapy HRT

Oestrogen conjugated tablets 625microgram and 1.2mg Premarin^®

Formulary

Estradiol patches/gel/spray

Formulary

Twice weekly matrix patches releasing approximately 25, 37.5 (Estradot® only), 50, 75 & 100 microgram/24 hours (Estradot®,Evorel®, Estraderm® MX);
Weekly matrix patches releasing approximately 25, 50, 75 & 100 microgram/24 hours (Femseven®);
Once weekly matrix patches releasing approx. 50 & 100 microgram estradiol/24 hours (Progynova TS®)
Estradiol 0.1% gel (Sandrena®)
Estradiol 0.06% gel (Oestrogel®)
- Approved for use in gender dysphoria therapy
- Approved for use as hormone replacement therapy
Estradiol 1.53mg/spray transdermal spray (Lenzetto®)
- Approved as an alternative to patches and gels for patients who have issues with absorption, find patch adhesive irritating or the gel messy

Estradiol tablets

Formulary

Ethinylestradiol

Formulary

Continuous combined HRT patch Evorel® Conti

Formulary

Combined cyclical HRT tablet Elleste Duet^®

Formulary

Pack of 16 x 1mg estradiol tablets + 12 x 1mg estradiol and 1mg norethisterone tablets

Combined cyclical HRT tablet Femoston^®

Formulary

Femoston® 1/10 Tablets:
- Pack of 14 x 1mg estradiol tablets + 14 tablets containing estradiol 1mg and dydrogesterone 10mg

Femoston® 2/10 Tablets:
- Pack of 14 x 2mg estradiol tablets + 14 tablets containing estradiol 2mg and dydrogesterone 10mg

Continuous combined HRT tablets Elleste-duet Conti, Kliofem, Kliovance, Femosten Conti, Premique-low dose

Formulary

Estradiol vaginal tablet

Formulary

10mg vaginal tablet
- Vagifem® 10mg vaginal tablets
- Vagirux® 10mg vaginal tablets (alternative)

Sequential combined cyclical HRT patch Evorel® Sequi

Formulary

Tibolone

Formulary

Links